NL-OMON20381已完成不适用
HOw feaR affects platelet aggRegability in healthy vOlunteeRs – a randomized crossover trial
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- one
- 入组人数
- 22
研究概览
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age between 18-30 years
- •-No prior medical history (Use of contraceptive medication with monophasic oral contraceptives or an intra-uterine device (i.e. Mirena) is permitted)
排除标准
- •-Alcohol intake within 24 hours prior to blood sampling
- •-Abnormal platelet count (i.e. <100 or > 400 x 109)
- •-NSAID intake within 24 hours prior to blood sampling
- •-Recent use of (other) antiplatelet drugs, anticoagulants or other drugs known to alter platelet function (e.g. serotonin reuptake inhibitors)
- •-Pregnancy
- •*Platelet count will be determined after the analyses of the first blood samples. If a subject turns out to have an abnormal platelet count, he or she will be excluded from the experiment.
研究者
相似试验
已完成
不适用
HOw feaR affects platelet aggRegability in healthy vOlunteeRs * a randomized cross-over study<br>Platelet activityplatelet aggregation10014523NL-OMON45733Vrije Universiteit Medisch Centrum23
尚未招募
不适用
Thrombogenicity and platelet reactivity as risk factors for postoperative microemboli signals in patients undergoing carotid endarterectomyNL-OMON25062MUMC100
招募中
不适用
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial AtherosclerosisIschemic StrokeIschemicStrokeTIANCT05518305University of California, Los Angeles250
尚未招募
不适用
Platelet function in 22q11.2 deletion syndromeNL-OMON24347one60
招募中
不适用
Exploring bleeding risk and platelet function combined with multiple omics techniques in 22q11.2 deletion syndromeDiGeorge syndromeVelocardiofacial syndrome100355341008362410039628NL-OMON55192Medisch Universitair Ziekenhuis Maastricht60